Xerosis (Dry Skin) – Pipeline Review, H2 2012

Publisher Name :
Date: 31-Oct-2012
No. of pages: 24
Inquire Before Buying

Xerosis (Dry Skin) – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, ‘Xerosis (Dry Skin) – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Xerosis (Dry Skin), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Xerosis (Dry Skin). Xerosis (Dry Skin) – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Xerosis (Dry Skin).
- A review of the Xerosis (Dry Skin) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Xerosis (Dry Skin) pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Xerosis (Dry Skin).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Xerosis (Dry Skin) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Xerosis (Dry Skin) – Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Xerosis (Dry Skin) Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Xerosis (Dry Skin) 6
Xerosis (Dry Skin) Therapeutics under Development by Companies 8
Late Stage Products 9
Comparative Analysis 9
Discovery and Pre-Clinical Stage Products 10
Comparative Analysis 10
Xerosis (Dry Skin) Therapeutics - Products under Development by Companies 11
Companies Involved in Xerosis (Dry Skin) Therapeutics Development 12
Syntopix Group Plc 12
Pierre Fabre Medicament 13
Xerosis (Dry Skin) - Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Route of Administration 15
Drug Profiles 17
HO/04/08 - Drug Profile 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
V0034-CR01B - Drug Profile 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Emollient-1 - Drug Profile 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Emollient-2 - Drug Profile 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Emollient-3 - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Xerosis (Dry Skin) Therapeutics - Dormant Products 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
Disclaimer 24

List of Tables
Number of Products Under Development for Xerosis (Dry Skin), H2 2012 6
Products under Development for Xerosis (Dry Skin) - Comparative Analysis, H2 2012 7
Number of Products under Development by Companies, H2 2012 8
Comparative Analysis by Late Stage Development, H2 2012 9
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2012 10
Products under Development by Companies, H2 2012 11
Syntopix Group Plc, H2 2012 12
Pierre Fabre Medicament, H2 2012 13
Assessment by Monotherapy Products, H2 2012 14
Assessment by Stage and Route of Administration, H2 2012 16
Xerosis (Dry Skin) Therapeutics - Dormant Products 22

List of Figures
Number of Products under Development for Xerosis (Dry Skin), H2 2012 6
Products under Development for Xerosis (Dry Skin) - Comparative Analysis, H2 2012 7
Products under Development by Companies, H2 2012 8
Late Stage Products, H2 2012 9
Discovery and Pre-Clinical Stage Products, H2 2012 10
Assessment by Monotherapy Products, H2 2012 14
Assessment by Route of Administration, H2 2012 15
Assessment by Stage and Route of Administration, H2 2012 16

  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Global Epilepsy Drug Market Continues to Grow Steadily
    The global epilepsy drug market has grown steadily in recent years with increased sales of anti-epileptic drugs which are targeted at reducing seizures. Epilepsy is a condition which affects the brain and is characterized with repeated seizures in the patient. Treatment for epilepsy usually involves the use of medicines known as anti-epileptic drugs which prevents [...]
  • Global Meat and Poultry Product Market to Witness Steady Growth
    As global demand for meat and poultry products continues to rise, the market for meat and poultry is also expected to grow steadily. The market for meat and poultry products is driven by rise in disposable income, growing awareness among consumers about the importance of adding protein to their diet, and change in eating habits. [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Scar – Pipeline Review, H2 2014
    Published: 31-Oct-2014        Price: US $2000 Onwards        Pages: 109
    Global Markets Direct's, ‘Scar Pipeline Review, H2 2014', provides an overview of the Scar's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Scar, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic de......
  • Chronic Plaque Psoriasis – Pipeline Review, H2 2014
    Published: 31-Oct-2014        Price: US $2000 Onwards        Pages: 100
    Global Markets Direct's, ‘Chronic Plaque Psoriasis Pipeline Review, H2 2014', provides an overview of the Chronic Plaque Psoriasis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Plaque Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases......
  • Psoriasis – Pipeline Review, H2 2014
    Published: 30-Oct-2014        Price: US $2000 Onwards        Pages: 399
    Global Markets Direct's, ‘Psoriasis Pipeline Review, H2 2014', provides an overview of the Psoriasis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the......
  • Contact Dermatitis – Pipeline Review, H2 2014
    Published: 25-Oct-2014        Price: US $2000 Onwards        Pages: 38
    Contact Dermatitis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Contact Dermatitis - Pipeline Review, H2 2014', provides an overview of the Contact Dermatitis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Contact Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates......
  • Acne Vulgaris – Pipeline Review, H2 2014
    Published: 30-Sep-2014        Price: US $2000 Onwards        Pages: 147
    Global Markets Direct's, ‘Acne Vulgaris - Pipeline Review, H2 2014', provides an overview of the Acne Vulgaris's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acne Vulgaris, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players i......
  • Vitiligo – Pipeline Review, H2 2014
    Published: 22-Sep-2014        Price: US $2000 Onwards        Pages: 50
    Global Markets Direct's, ‘Vitiligo Pipeline Review, H2 2014', provides an overview of the Vitiligo's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vitiligo, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the th......
  • Epidermolysis Bullosa – Pipeline Review, H2 2014
    Published: 22-Sep-2014        Price: US $2000 Onwards        Pages: 59
    Global Markets Direct's, ‘Epidermolysis Bullosa Pipeline Review, H2 2014', provides an overview of the Epidermolysis Bullosa's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Epidermolysis Bullosa, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also......
  • Keloids – Pipeline Review, H2 2014
    Published: 15-Sep-2014        Price: US $2000 Onwards        Pages: 52
    Global Markets Direct's, ‘Keloids Pipeline Review, H2 2014', provides an overview of the Keloids's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Keloids, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the thera......
  • Eczema – Pipeline Review, H2 2014
    Published: 15-Sep-2014        Price: US $2000 Onwards        Pages: 45
    Global Markets Direct's, ‘Eczema Pipeline Review, H2 2014', provides an overview of the Eczema's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Eczema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs